Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00221390 · ClinicalTrials.gov registry record · Phase 2
Trial of Ropinirole in Motor Recovery After Stroke
A Phase 2 study, sponsored by University of California, Irvine.
- Completed
- Registry status
- Phase 2
- Development phase
- 52
- Enrollment target
NCT00221390 is a Phase 2 study that has completed, run by University of California, Irvine. The registered enrollment target is 52 participants.
The verdict
NCT00221390, a Phase 2 study, has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 52 participants
- Enrollment target
Study Summary
The purpose of this study is to assess efficacy, as well as safety, of Ropinirole in improving movement among patients with chronic stroke.
Interventions
- DRUG Ropinirole (+ physical therapy)
- DRUG (vs.) Placebo + physical therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 52 participants |
| Start Date | 2003-10 |
| Est. Completion | 2007-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00221390
The ClinicalTrials.gov registry entry for NCT00221390 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Irvine, which has 368 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ropinirole (+ physical therapy) is the first listed.
NCT00221390 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00221390 about?
NCT00221390 is a clinical study titled "Trial of Ropinirole in Motor Recovery After Stroke". The purpose of this study is to assess efficacy, as well as safety, of Ropinirole in improving movement among patients with chronic stroke.
What is the current status of trial NCT00221390?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 52 participants. The study started on 2003-10. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00221390?
The interventions under investigation include: Ropinirole (+ physical therapy) (DRUG), (vs.) Placebo + physical therapy (DRUG).
Who is sponsoring clinical trial NCT00221390?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.